Acelrx Pharma (ACRX) Files 5.55M Common Shelf for Shareholders
Tweet
Share
E-mailGet Alerts ACRX Hot Sheet
Join SI Premium – FREE
Acelrx Pharmaceuticals, Inc. (Nasdaq: ACRX) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to 5,552,440 shares of its common stock on behalf of selling shareholders.
The company will not receive proceeds from the secondary offering.
The company will not receive proceeds from the secondary offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karman Line Acquisition closes $200M IPO on Nasdaq
- EigenQ files draft S-4 with SEC in SPAC merger with Silicon Valley Acquisition
- Aurora Cannabis acquires two UK pharma firms for £2.1 million
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
